DE60208180D1 - Modifiziertes, als medikamentvorstufe anwendbares cyclosporin und dessen verwendung - Google Patents

Modifiziertes, als medikamentvorstufe anwendbares cyclosporin und dessen verwendung

Info

Publication number
DE60208180D1
DE60208180D1 DE60208180T DE60208180T DE60208180D1 DE 60208180 D1 DE60208180 D1 DE 60208180D1 DE 60208180 T DE60208180 T DE 60208180T DE 60208180 T DE60208180 T DE 60208180T DE 60208180 D1 DE60208180 D1 DE 60208180D1
Authority
DE
Germany
Prior art keywords
applicable
medicament preparation
modified cyclosporin
cyclosporin
modified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60208180T
Other languages
English (en)
Other versions
DE60208180T2 (de
Inventor
Roland Wenger
Manfred Mutter
Arnaud Hamel
Francis Hubler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ophthalmopharma Ag Sarnen Ch
Original Assignee
Debiopharm SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Debiopharm SA filed Critical Debiopharm SA
Publication of DE60208180D1 publication Critical patent/DE60208180D1/de
Application granted granted Critical
Publication of DE60208180T2 publication Critical patent/DE60208180T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Transplantation (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60208180T 2001-04-20 2002-04-22 Modifiziertes, als medikamentvorstufe anwendbares cyclosporin und dessen verwendung Expired - Lifetime DE60208180T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH72001 2001-04-20
CH7202001 2001-04-20
PCT/CH2002/000222 WO2002085928A2 (fr) 2001-04-20 2002-04-22 Cyclosporine modifiee utilisable en tant que pro-drogue et son utilisation

Publications (2)

Publication Number Publication Date
DE60208180D1 true DE60208180D1 (de) 2006-01-26
DE60208180T2 DE60208180T2 (de) 2006-08-17

Family

ID=4531478

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60208180T Expired - Lifetime DE60208180T2 (de) 2001-04-20 2002-04-22 Modifiziertes, als medikamentvorstufe anwendbares cyclosporin und dessen verwendung

Country Status (17)

Country Link
US (1) US6995139B2 (de)
EP (1) EP1379547B1 (de)
JP (1) JP4588979B2 (de)
KR (1) KR100932859B1 (de)
CN (1) CN1507451A (de)
AT (1) ATE313557T1 (de)
AU (1) AU2002245996B8 (de)
BR (1) BR0208923A (de)
CA (1) CA2444278C (de)
DE (1) DE60208180T2 (de)
ES (1) ES2256450T3 (de)
IL (1) IL158385A0 (de)
MX (1) MXPA03009586A (de)
RU (1) RU2290196C2 (de)
UA (1) UA75136C2 (de)
WO (1) WO2002085928A2 (de)
ZA (1) ZA200307794B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7186855B2 (en) 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7354574B2 (en) * 2002-11-07 2008-04-08 Advanced Ocular Systems Limited Treatment of ocular disease
US7083803B2 (en) 2003-09-19 2006-08-01 Advanced Ocular Systems Limited Ocular solutions
US7087237B2 (en) 2003-09-19 2006-08-08 Advanced Ocular Systems Limited Ocular solutions
EP1768662A2 (de) 2004-06-24 2007-04-04 Novartis Vaccines and Diagnostics, Inc. Immunstimulatoren kleiner moleküle und assays für deren nachweis
AU2006270041B2 (en) 2005-07-18 2011-08-18 Minu, Llc Enhanced ocular neuroprotection/neurostimulation
US7696166B2 (en) 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
US7696165B2 (en) 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
TW200820963A (en) * 2006-07-28 2008-05-16 Xenoport Inc Acyloxyalkyl carbamate prodrugs of α-amino acids, methods of synthesis and use
US8394763B2 (en) 2007-09-26 2013-03-12 Oregon Health & Science University Cyclic undecapeptides and derivatives as multiple sclerosis therapies
WO2009098533A1 (en) * 2008-02-08 2009-08-13 Debiopharm Sa Non -immunosuppressive cyclosporin for the treatment of muscular dystrophy
GB0912584D0 (en) * 2009-07-20 2009-08-26 Ucl Business Plc Cyclosporin conjugates
DK2651965T3 (en) 2010-12-15 2019-02-18 Contravir Pharmaceuticals Inc CYCLOSPORIN ANALOGUAL MODULES MODIFIED BY AMINO ACID 1 AND 3
AR090964A1 (es) * 2012-05-09 2014-12-17 Novartis Ag Proceso para la elaboracion de undecapeptidos ciclicos
CN113388002A (zh) * 2021-06-10 2021-09-14 梯尔希（南京）药物研发有限公司 一种环孢菌素相关化合物的制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4396542A (en) * 1980-02-14 1983-08-02 Sandoz Ltd. Method for the total synthesis of cyclosporins, novel cyclosporins and novel intermediates and methods for their production
EP0034567B1 (de) * 1980-02-14 1984-11-07 Sandoz Ag Verfahren zur Totalsynthese von Cyclosporinen und neue Cyclosporine
US5169773A (en) * 1984-10-04 1992-12-08 Sandoz Ltd. Monoclonal antibodies to cyclosporins
DE3478398D1 (en) * 1984-10-10 1989-07-06 Ile De France Synergistic contraceptive mixture
US4764503A (en) * 1986-11-19 1988-08-16 Sandoz Ltd. Novel cyclosporins
FI111730B (fi) * 1990-11-02 2003-09-15 Novartis Ag Menetelmä ei-immunosuppressiivisen syklosporiinin valmistamiseksi
US6187547B1 (en) * 1993-09-08 2001-02-13 Novartis Ag Assay kit
GB9624038D0 (en) * 1996-11-19 1997-01-08 Sandoz Ltd Organic compounds
US6017879A (en) * 1998-04-03 2000-01-25 B.M.R.A. Corporation B.V. Template associated NPY Y2-receptor agonists
DE69928938T2 (de) 1998-07-01 2006-08-17 Debiopharm S.A. Neues cyclosporin mit verbesserter wirkung
US6204257B1 (en) * 1998-08-07 2001-03-20 Universtiy Of Kansas Water soluble prodrugs of hindered alcohols
EP1150999B1 (de) * 1999-02-05 2006-06-21 Debiopharm S.A. Cyclosporin-derivate und verfahren zu deren herstellung
US6765019B1 (en) * 1999-05-06 2004-07-20 University Of Kentucky Research Foundation Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids
WO2001005819A1 (en) * 1999-07-15 2001-01-25 Kuhnil Pharm. Co., Ltd. Novel water soluble-cyclosporine conjugated compounds
US6593292B1 (en) * 1999-08-24 2003-07-15 Cellgate, Inc. Compositions and methods for enhancing drug delivery across and into epithelial tissues

Also Published As

Publication number Publication date
ES2256450T3 (es) 2006-07-16
CN1507451A (zh) 2004-06-23
US20040138108A1 (en) 2004-07-15
CA2444278A1 (en) 2002-10-31
RU2290196C2 (ru) 2006-12-27
KR100932859B1 (ko) 2009-12-23
AU2002245996B8 (en) 2005-07-14
BR0208923A (pt) 2004-04-27
ZA200307794B (en) 2004-07-19
EP1379547A2 (de) 2004-01-14
WO2002085928A3 (fr) 2003-04-17
MXPA03009586A (es) 2004-05-24
US6995139B2 (en) 2006-02-07
EP1379547B1 (de) 2005-12-21
UA75136C2 (en) 2006-03-15
RU2003133742A (ru) 2005-03-20
IL158385A0 (en) 2004-05-12
ATE313557T1 (de) 2006-01-15
JP4588979B2 (ja) 2010-12-01
AU2002245996B2 (en) 2005-06-30
DE60208180T2 (de) 2006-08-17
WO2002085928A2 (fr) 2002-10-31
CA2444278C (en) 2011-11-22
KR20030094357A (ko) 2003-12-11
JP2004536051A (ja) 2004-12-02

Similar Documents

Publication Publication Date Title
DE60208180D1 (de) Modifiziertes, als medikamentvorstufe anwendbares cyclosporin und dessen verwendung
ATE300306T1 (de) Pharmazeutische zusammensetzung zur ophtalmologischen und rhinologischen anwendung
DE602007013391D1 (de) Cyclosporins zur behandlung und vorbeugung von augenerkrankungen
SE0001899D0 (sv) New compounds
HK1080459A1 (en) Novel pyrimidineamide derivatives and the use thereof
NO20015584L (no) Langtidsvarende insulintropiske peptider og konjugater samt anvendelse for fremstilling av medikamenter for behandling
MX2007007671A (es) Metodo para producir suspensiones o liofilizados esteriles de complejos de peptidos basicos escasamente solubles, formulaciones farmaceuticas que los contienen y el uso de estas conmo medicamentos.
NO20042161L (no) Inhibitorer av 11-beta-hydroksysteroid dehydrogenase type 1
TW200736255A (en) 5-(Substituted)-pyrazolopiperidines
IL159087A0 (en) Bridged bicyclic compounds and pharmaceutical compositions containing the same
MY144318A (en) Methods of treating hiv infection.
CA2583764A1 (en) Thrombopoietin activity modulating compounds and methods
BR0313747A (pt) Inibidores de transcriptase reversa de não-nucleosìdeo
UY27455A1 (es) Derivados n-(1,4,5,6-tetrahidro-ciclopentapirazol -3-il)- sustituidos. su obtención y uso como fármacos.
HK1068606A1 (en) Novel aminobenzoephenones
NO20073176L (no) Nye medikamenter for behandling av luftveissykdommer
EP1379508A4 (de) N-(aryl)-2-arylethensulfonamide und ihre therapeutischen anwendungen
GEP20063869B (en) Novel cyclohexyl sulphones
MXPA02011533A (es) Nuevas formulaciones de alfa-2,4-disulfofenil-n-terc-butilnitrona.
MY128529A (en) Use of cilobradine or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
DK1268522T3 (da) LH-RH-antagonister samt fremstilling deraf og anvendelse deraf som lægemidler
DE60327249D1 (de) Anthranilsäureamide und ihre pharmazeutische verwendung
DE502007006951D1 (de) Arzneimittelkombinationen zur behandlung von atemwegserkrankungen
ATE425741T1 (de) Arzneizubereitung und deren anwendung zur behandlung von erkrankungen des inneren ohres
DE60227008D1 (de) Neue thiophenacylhydrazinoderivate, verfahren zu deren herstellung, deren verwendung als arzneimittel, pharmazeutische zusammensetzungen und neue anwendungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: OPHTHALMOPHARMA AG, SARNEN, CH